DoP to soon come up with scheme for establishing common facilities in bulk drug parks
|
Swati Rana, Mumbai
October 27 , 2016
|
|
The Department of Pharmaceuticals (DoP) will soon come up with a scheme
for assisting the pharmaceutical industry in establishing common
facilities in the bulk drug parks, as it is under the final stage of
approval from the Union finance ministry. The scheme is one of the
recommendations made by the Katoch Committee which was set up by the
government seeking suggestions to boost the API manufacturing in India.
Sudhansh
Pant, joint secretary of DoP, says, “The recommendation by the Katoch
Committee has been examined and from those recommendations, the concept
of providing assistance to the bulk drug parks have come up. The scheme
will help in reducing the manufacturing cost of APIs. For time being,
this assistance to the bulk drug parks by means of assisting the common
facilities is in the advance stage and may be over the period of time it
will soon be in place.”
Emphasizing on the initiative taken by
the government in encouraging the innovation in pharma industry, Pant
further says, “To encourage the innovation there is a proposal for the
venture capital fund specifically for the pharma sector which is at
advance stages of consideration. There are schemes for the
infrastructure support for supporting the common facilities, pharma
clusters and bulk drug parks and all these efforts are going on by the
government. These are at various stages of approval or consideration.”
The
Katoch Report has suggested the establishment of six large API
intermediate clusters in five to six states. These parks could be
allotted to large bulk, medium and small manufacturers on the basis of a
formula to be specified in the guidelines which may be prepared by the
DoP. These bulk drug parks will have common facilities like testing,
power and effluent treatment plants. Besides, there will be common
utilities and services such as storage, testing laboratories, IPR
management, designing and guest house/accommodation, maintained by a
separate special purpose vehicle.
According to reports, the API
sector is valued at around US$ 120 billion and projected to grow at a
CAGR of 6.5 per cent to US$ 185.9 billion by 2020. India has over 2,000
API manufacturing units producing nearly 1,500 APIs, which is estimated
at US$ 9 billion. Out of this nearly 50 per cent is for export.
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|